المؤلفون: Cochran, JM, Chung, SH, Leproux, A, Baker, WB, Busch, DR, DeMichele, AM, Tchou, J, Tromberg, BJ, Yodh, AG

المصدر: Physics in Medicine and Biology. 62(12)

مصطلحات موضوعية: Biomedical Imaging, Bioengineering, Clinical Research, Cancer, Breast Cancer, Adult, Aged, Breast Neoplasms, Female, Humans, Longitudinal Studies, Middle Aged, Neoadjuvant Therapy, Optical Imaging, Oxygen, Spectrum Analysis, diffuse correlation spectroscopy, diffuse optical spectroscopy, neoadjuvant chemotherapy, chemotherapy monitoring, breast cancer imaging, tumor blood flow, tumor metabolism, Other Physical Sciences, Biomedical Engineering, Clinical Sciences, Nuclear Medicine & Medical Imaging

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/453142ps

المؤلفون: McCrae, KR, DeMichele, AM, Pandhi, P, Balsai, MJ, Samuels, P, Graham, C, Lala, PK, Cines, DB

المصدر: Blood; November 1993, Vol. 82 Issue: 9 p2730-2741, 12p

المؤلفون: Magbanua MJM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., Ahmed Z; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., Sayaman RW; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., Brown Swigart L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., Hirst GL; Department of Surgery, University of California San Francisco, San Francisco, California., Yau C; Department of Surgery, University of California San Francisco, San Francisco, California., Wolf DM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., Li W; Department of Radiology, University of California San Francisco, San Francisco, California., Delson AL; Breast Science Advocacy Core, University of California San Francisco, San Francisco, California., Perlmutter J; Breast Science Advocacy Core, University of California San Francisco, San Francisco, California., Pohlmann P; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Symmans WF; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas., Yee D; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota., Hylton NM; Department of Radiology, University of California San Francisco, San Francisco, California., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, California., DeMichele AM; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Rugo HS; Division of Hematology/Oncology, University of California San Francisco, San Francisco, California., van 't Veer LJ; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2444-2451.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*/blood , Breast Neoplasms*/blood , Breast Neoplasms*/diagnosis , Breast Neoplasms*/drug therapy , Cell-Free Nucleic Acids*/blood , Neoadjuvant Therapy* , Neoplasm Recurrence, Local*/blood , Neoplasm Recurrence, Local*/diagnosis , Neoplasm Recurrence, Local*/drug therapy, Adult ; Aged ; Female ; Humans ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Circulating Tumor DNA/blood ; Circulating Tumor DNA/genetics ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptor, ErbB-2/genetics ; Treatment Outcome ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/pathology ; Triple Negative Breast Neoplasms/blood ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/genetics

المؤلفون: Smith KL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.; Sibley Memorial Hospital, Washington, District of Columbia, USA., Zhao F; Dana Farber Cancer Institute, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Biostatistics Center, Boston, Massachusetts, USA., Mayer IA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Tevaarwerk AJ; Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA., Garcia SF; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Arteaga CL; University of Texas Southwestern Simmons Cancer Center, Dallas, Texas, USA., Symmans WF; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Park BH; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Burnette BL; Cancer Research of Wisconsin and Northern Michigan (CROWN) NCORP, Green Bay, Wisconsin, USA., Makower DF; Montefiore Medical Center, Bronx, New York, USA., Block M; Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, USA., Morley KA; St Joseph Mercy Hospital, Ann Arbor, Michigan, USA., Jani CR; Phoebe Putney Memorial Hospital, Albany, Georgia, USA., Mescher C; Metro-Minnesota Community Oncology Research Consortium, St Louis Park, Minnesota, USA., Dewani SJ; Columbus Oncology and Hematology Associates Inc., Columbus, Ohio, USA., Brown-Glaberman U; University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA., Flaum LE; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Mayer EL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Sikov WM; Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA., Rodler ET; University of California, Davis, Davis, California, USA., DeMichele AM; University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, USA., Sparano JA; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York, USA., Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA., Wagner LI; Wake Forest University Health Sciences, Winston-Salem, North Carolina, USA.

المصدر: Cancer [Cancer] 2024 May 15; Vol. 130 (10), pp. 1747-1757. Date of Electronic Publication: 2024 Jan 18.

نوع المنشور: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Capecitabine*/therapeutic use , Capecitabine*/adverse effects , Patient Reported Outcome Measures* , Quality of Life* , Triple Negative Breast Neoplasms*/drug therapy, Adult ; Aged ; Female ; Humans ; Middle Aged ; Chemotherapy, Adjuvant/methods ; Neoplasm, Residual ; Platinum/therapeutic use

المؤلفون: Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois., Yau C; University of California San Francisco, San Francisco, California., Petricoin EF; George Mason University, Fairfax, Virginia., Wolf DM; University of California San Francisco, San Francisco, California., Lang JE; Cleveland Clinic, Cleveland, Ohio., Chien AJ; University of California San Francisco, San Francisco, California., Haddad T; Mayo Clinic Rochester, Rochester, Minnesota., Forero-Torres A; University of Alabama at Birmingham, Birmingham, Alabama., Wallace AM; University of California San Diego, La Jolla, California., Kaplan H; Swedish Cancer Institute, Seattle, Washington., Pusztai L; Yale University, New Haven, Connecticut., Euhus D; Johns Hopkins University, Baltimore, Maryland., Nanda R; University of Chicago, Chicago, Illinois., Elias AD; University of Colorado Denver, Aurora, Colorado., Clark AS; University of Pennsylvania, Philadelphia, Pennsylvania., Godellas C; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois., Boughey JC; Mayo Clinic Rochester, Rochester, Minnesota., Isaacs C; Georgetown University, Washington, District of Columbia., Tripathy D; University of Texas MD Anderson Cancer Center, Houston, Texas., Lu J; University of Southern California, Los Angeles, California., Yung RL; University of Washington, Seattle, Washington., Gallagher RI; George Mason University, Fairfax, Virginia., Wulfkuhle JD; George Mason University, Fairfax, Virginia., Brown-Swigart L; University of California San Francisco, San Francisco, California., Krings G; University of California San Francisco, San Francisco, California., Chen YY; University of California San Francisco, San Francisco, California., Potter DA; University of Minnesota, Minneapolis, Minnesota., Stringer-Reasor E; University of Alabama at Birmingham, Birmingham, Alabama., Blair S; University of California San Diego, La Jolla, California., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, California., Hirst GL; University of California San Francisco, San Francisco, California., Singhrao R; University of California San Francisco, San Francisco, California., Buxton M; University of California San Francisco, San Francisco, California., Clennell JL; University of California San Francisco, San Francisco, California., Sanil A; Berry Consultants, LLC, Houston, Texas., Berry S; Berry Consultants, LLC, Houston, Texas., Asare AL; Quantum Leap Healthcare Collaborative, San Francisco, California., Matthews JB; University of California San Francisco, San Francisco, California., DeMichele AM; University of Pennsylvania, Philadelphia, Pennsylvania., Hylton NM; University of California San Francisco, San Francisco, California., Melisko M; University of California San Francisco, San Francisco, California., Perlmutter J; Gemini Group, Ann Arbor, Michigan., Rugo HS; University of California San Francisco, San Francisco, California., Symmans WF; University of Texas MD Anderson Cancer Center, Houston, Texas., Van't Veer LJ; University of California San Francisco, San Francisco, California., Yee D; University of Minnesota, Minneapolis, Minnesota., Berry DA; Berry Consultants, LLC, Houston, Texas., Esserman LJ; University of California San Francisco, San Francisco, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 729-740.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Recombinant Fusion Proteins*, Female ; Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bayes Theorem ; Neoadjuvant Therapy ; Paclitaxel/adverse effects ; Receptor, ErbB-2/metabolism ; Receptor, TIE-2 ; Trastuzumab/adverse effects

المؤلفون: Gallagher RI; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA. Electronic address: rgallag3@gmu.edu., Wulfkuhle J; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA. Electronic address: jwulfkuh@gmu.edu., Wolf DM; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Brown-Swigart L; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Yau C; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., O'Grady N; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., Basu A; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., Lu R; Quantum Leap Healthcare Collaborative, San Francisco, CA 94118, USA., Campbell MJ; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., Magbanua MJ; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Coppé JP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, CA 94118, USA., Sit L; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., Matthews JB; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., Perlmutter J; Gemini Group, Ann Arbor, MI 48107, USA., Hylton N; Department of Radiology, University of California, San Francisco, San Francisco, CA 94143, USA., Liu MC; Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA., Symmans WF; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rugo HS; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94158, USA., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA., DeMichele AM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Yee D; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Pohlmann PR; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hirst GL; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., Esserman LJ; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA., van 't Veer LJ; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA. Electronic address: epetrico@gmu.edu.

مؤلفون مشاركون: I-SPY 2 Investigators

المصدر: Cell reports. Medicine [Cell Rep Med] 2023 Dec 19; Vol. 4 (12), pp. 101312. Date of Electronic Publication: 2023 Dec 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm*/genetics , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/pathology, Humans ; Neoadjuvant Therapy ; Biomarkers ; Gene Expression Profiling

المؤلفون: Kyalwazi B; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas., Yau C; Department of Surgery, University of California, San Francisco., Campbell MJ; Department of Surgery, University of California, San Francisco., Yoshimatsu TF; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Chien AJ; Department of Hematology Oncology and Surgery, University of California, San Francisco Helen Diller Comprehensive Cancer Center, San Francisco., Wallace AM; Division of Breast Surgery and the Comprehensive Breast Health Center, University of California San Diego, La Jolla., Forero-Torres A; Division of Hematology/Oncology, The University of Alabama at Birmingham., Pusztai L; Department of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut., Ellis ED; Swedish Cancer Institute, Seattle, Washington., Albain KS; Division of Hematology-Oncology, Department of Medicine, University of Minnesota, Minneapolis., Blaes AH; Division of Hematology-Oncology, Department of Medicine, University of Minnesota, Minneapolis., Haley BB; Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas., Boughey JC; Department of Surgery, Mayo Clinic, Rochester, Minnesota., Elias AD; University of Colorado Cancer Center, Aurora., Clark AS; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia., Isaacs CJ; Department of Medicine, Georgetown University, Washington, DC., Nanda R; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Han HS; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida., Yung RL; Department of Medicine, School of Medicine, University of Washington, Seattle., Tripathy D; Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Edmiston KK; Inova Health System, Fairfax, Virginia., Viscusi RK; Department of Surgery, University of Arizona College of Medicine, Tucson., Northfelt DW; Department of Medical Oncology, Mayo Clinic, Phoenix, Arizona., Khan QJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, California., Hirst GL; Department of Surgery, University of California, San Francisco., Lu R; Quantum Leap Healthcare Collaborative, San Francisco, California., Symmans WF; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston., Yee D; Division of Hematology-Oncology, Department of Medicine, University of Minnesota, Minneapolis., DeMichele AM; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia., van 't Veer LJ; Department of Laboratory Medicine, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco., Esserman LJ; Department of Surgery, University of California, San Francisco., Olopade OI; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois.

المصدر: JAMA network open [JAMA Netw Open] 2023 Dec 01; Vol. 6 (12), pp. e2349646. Date of Electronic Publication: 2023 Dec 01.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Racial Groups*, Female ; Humans ; Retrospective Studies ; Transcriptome ; Pathologic Complete Response ; Disease-Free Survival

المؤلفون: Magbanua MJM; University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: mark.magbanua@ucsf.edu., Brown Swigart L; University of California, San Francisco, San Francisco, CA 94143, USA., Ahmed Z; University of California, San Francisco, San Francisco, CA 94143, USA., Sayaman RW; University of California, San Francisco, San Francisco, CA 94143, USA., Renner D; Natera, Inc., Austin, TX 78753, USA., Kalashnikova E; Natera, Inc., Austin, TX 78753, USA., Hirst GL; University of California, San Francisco, San Francisco, CA 94143, USA., Yau C; University of California, San Francisco, San Francisco, CA 94143, USA., Wolf DM; University of California, San Francisco, San Francisco, CA 94143, USA., Li W; University of California, San Francisco, San Francisco, CA 94143, USA., Delson AL; UCSF Breast Science Advocacy Core, San Francisco, CA 94143, USA., Asare S; Quantum Leap Healthcare Collaborative, San Francisco, CA 94118, USA., Liu MC; Natera, Inc., Austin, TX 78753, USA; Mayo Clinic, Rochester, MN 55905, USA., Albain K; Loyola University Chicago, Maywood, IL 60153, USA., Chien AJ; University of California, San Francisco, San Francisco, CA 94143, USA., Forero-Torres A; University of Alabama at Birmingham, Birmingham, AL 35233, USA., Isaacs C; Georgetown University, Washington, DC 20007, USA., Nanda R; University of Chicago, Chicago, IL 60637, USA., Tripathy D; University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rodriguez A; Natera, Inc., Austin, TX 78753, USA., Sethi H; Natera, Inc., Austin, TX 78753, USA., Aleshin A; Natera, Inc., Austin, TX 78753, USA., Rabinowitz M; Natera, Inc., Austin, TX 78753, USA., Perlmutter J; UCSF Breast Science Advocacy Core, San Francisco, CA 94143, USA., Symmans WF; University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yee D; University of Minnesota, Minneapolis, MN 55455, USA., Hylton NM; University of California, San Francisco, San Francisco, CA 94143, USA., Esserman LJ; University of California, San Francisco, San Francisco, CA 94143, USA., DeMichele AM; University of Pennsylvania, Philadelphia, PA 19104, USA., Rugo HS; University of California, San Francisco, San Francisco, CA 94143, USA., van 't Veer LJ; University of California, San Francisco, San Francisco, CA 94143, USA.

المصدر: Cancer cell [Cancer Cell] 2023 Jun 12; Vol. 41 (6), pp. 1091-1102.e4. Date of Electronic Publication: 2023 May 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/genetics , Circulating Tumor DNA*/genetics, Humans ; Female ; Neoadjuvant Therapy ; Clinical Relevance ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biology ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism

المؤلفون: Brown JC; Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA, USA.; LSU Health Sciences Center New Orleans School of Medicine, 1901 Perdido St, New Orleans, LA, USA.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, 533 Bolivar St, New Orleans, LA, USA., Sturgeon K; Penn State College of Medicine, 400 University Drive, Hershey, PA, 17033, USA., Sarwer DB; Temple University College of Public Health, 1101 W. Montgomery Ave, Philadelphia, PA, USA., Troxel AB; New York University Grossman School of Medicine, 180 Madison Ave, New York, NY, USA., DeMichele AM; Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA, USA., Denlinger CS; Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, USA., Schmitz KH; Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA. schmitzk@upmc.edu.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 May; Vol. 199 (1), pp. 109-117. Date of Electronic Publication: 2023 Mar 18.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/therapy , Cancer Survivors*, Humans ; Female ; Diet ; Oxidative Stress ; Telomere/genetics

المؤلفون: Clark AS; University of Pennsylvania, Philadelphia, Pennsylvania., Hong F; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Finn RS; University of California, Los Angeles, Los Angeles, California., DeMichele AM; University of Pennsylvania, Philadelphia, Pennsylvania., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Zwiebel J; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Arnaldez FI; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Gray RJ; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Wang V; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Patton D; Center for Biomedical Informatics and Information Technology, NCI, Bethesda, Maryland., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland., Hamilton SR; City of Hope National Medical Center, Duarte, California., Copur MS; Catholic Health Initiatives NCORP, Grand Island, Nebraska., Kasbari SS; Southeast COR NCORP, Goldsboro, North Carolina., Thind R; University of Kentucky, Lexington, Kentucky., Conley BA; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, Texas., O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania., Harris LN; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Chen AP; Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 14; Vol. 29 (8), pp. 1477-1483.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Neutropenia*, Humans ; Female ; Piperazines ; Pyridines ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclin D1/genetics